Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FBAMF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,812
Award facts
- Contract value 100% obligated
- $44,811.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $44,811.90 to AmerisourceBergen Drug Corp for the supply of Multaq (dronedarone) 400 mg tablets in a quantity of 60 units. This non-competitive, firm fixed-price delivery order was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the federal government's ongoing pharmaceutical procurement needs for military and veteran healthcare systems.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FBAMF?
SPE2DB26FBAMF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FBAMF worth?
The government has obligated $44,812 on SPE2DB26FBAMF.
Is contract SPE2DB26FBAMF an order under another contract?
Yes. SPE2DB26FBAMF is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB26FBAMF competed?
The extent of competition for SPE2DB26FBAMF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award